News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
Investment of approximately US$ 2.0 million
02-Feb-2005 - QIAGEN N.V. and Protedyne Corporation announced that they have expanded their strategic alliance to jointly market and cross-promote the use of Protedyne's BioCube System in conjunction with QIAGEN's QIAamp nucleic acid purification products as an integrated fully automated ultra-high throughput ...
QIAGEN to Keep its siRNA Business and to Retain Preferred Access to Synthetic DNA Supply
03-Aug-2004 - QIAGEN N.V. announced that it has sold its synthetic DNA business to a management team previously employed at QIAGEN and which operated parts of this business. The new company is backed by private investors and QIAGEN will retain a minority stake of 16%. The new company, to be named Operon ...
01-Jul-2004 - QIAGEN N.V. announced that it has sold its synthetic DNA business to a management team previously employed at QIAGEN and which operated parts of this business. The new company is backed by private investors and QIAGEN will retain a minority stake of 16%. The new company, to be named Operon ...
14-Jun-2004 - Venlo and Windsor QIAGEN and Protedyne Corporation, a premier supplier of industrial robotics for research, drug discovery and testing laboratories, announced that they have entered into a collaboration to develop a fully automated ultra high-throughput sample preparation system for ...
05-May-2004 - Venlo, The Netherlands - QIAGEN N.V. announced that it has launched a series of off-the-shelf human library siRNA sets, covering a broad gene family selection including kinases, GPCRs, apoptosis related genes, and oncogenes, to name a few. All siRNA designs were accomplished using the ...
04-May-2004 - Venlo, The Netherlands - QIAGEN, N.V. announced that Wolfgang Fries has joined QIAGEN and has assumed responsibility for QIAGEN's world wide human resource management as Vice President Global Human Resources starting April 1, 2004. Mr. Fries will be a member of QIAGEN's Executive Committee and ...
18-Feb-2004 - Venlo, The Netherlands. QIAGEN, N.V. announced that it has launched the first CE-certified generic sample preparation kit fulfilling the requirements of the EU's recent in-vitro diagnostic directive. The newly developed QIAamp DSP DNA Blood Mini Kit is available for the European markets and is ...
16-Dec-2003 - QIAGEN N.V. announced that it has licensed from Novartis Pharma AG a novel algorithm for the selection of highly functional target sequences for RNA interference applications. More than 3000 randomly designed synthetic siRNA duplexes, against 34 targets were analyzed for functionality. Based on ...
12-Dec-2003 - QIAGEN GmbH and artus GmbH announced that they have entered into a manufacturing and supply agreement. Pursuant to this agreement, artus will integrate QIAGEN's nucleic acid sample preparation products in its diagnostic systems for use in the detection of a variety of infectious diseases such as ...
Epoch to License and Supply MGB Eclipse™ Technologies For Gene Expression Products
08-Nov-2002 - Epoch Biosciences, Inc. and QIAGEN N.V., today announced that QIAGEN will become a co-exclusive worldwide sales and marketing partner to the research field for products that incorporate Epoch Biosciences' MGB Eclipse™ Probe Systems for real-time measurement of gene expression. Epoch will ...
© 1997-2024 LUMITOS AG, All rights reserved